SI2408426T1 - Oftalmični sestavki na osnovi polinenasičenih omega-3 in omega-6 maščobnih kislin - Google Patents
Oftalmični sestavki na osnovi polinenasičenih omega-3 in omega-6 maščobnih kislinInfo
- Publication number
- SI2408426T1 SI2408426T1 SI201031418A SI201031418A SI2408426T1 SI 2408426 T1 SI2408426 T1 SI 2408426T1 SI 201031418 A SI201031418 A SI 201031418A SI 201031418 A SI201031418 A SI 201031418A SI 2408426 T1 SI2408426 T1 SI 2408426T1
- Authority
- SI
- Slovenia
- Prior art keywords
- omega
- fatty acids
- compositions based
- ophthalmic compositions
- polyunsaturated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2009A000119A IT1393419B1 (it) | 2009-03-19 | 2009-03-19 | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
EP10717302.3A EP2408426B1 (en) | 2009-03-19 | 2010-03-18 | Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
PCT/IT2010/000119 WO2010106571A2 (en) | 2009-03-19 | 2010-03-18 | Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2408426T1 true SI2408426T1 (sl) | 2017-04-26 |
Family
ID=41213320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201031418A SI2408426T1 (sl) | 2009-03-19 | 2010-03-18 | Oftalmični sestavki na osnovi polinenasičenih omega-3 in omega-6 maščobnih kislin |
Country Status (18)
Country | Link |
---|---|
US (1) | US8957110B2 (sl) |
EP (1) | EP2408426B1 (sl) |
KR (1) | KR101677308B1 (sl) |
CN (1) | CN102355889B (sl) |
BR (1) | BRPI1009281A2 (sl) |
CA (1) | CA2754568C (sl) |
DK (1) | DK2408426T3 (sl) |
ES (1) | ES2617683T3 (sl) |
HK (1) | HK1166714A1 (sl) |
HU (1) | HUE031869T2 (sl) |
IT (1) | IT1393419B1 (sl) |
MX (1) | MX2011009740A (sl) |
PL (1) | PL2408426T3 (sl) |
PT (1) | PT2408426T (sl) |
RS (1) | RS55859B1 (sl) |
RU (1) | RU2545675C2 (sl) |
SI (1) | SI2408426T1 (sl) |
WO (1) | WO2010106571A2 (sl) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2764802A1 (en) | 2009-06-05 | 2010-12-09 | Allergan, Inc. | Artificial tears and therapeutic uses |
US20110237548A1 (en) * | 2009-07-23 | 2011-09-29 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome using omega choline |
US20130011469A1 (en) | 2009-07-23 | 2013-01-10 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Krill oil and carotenoid composition, associated method and delivery system |
US20130295171A1 (en) | 2009-07-23 | 2013-11-07 | U.S NUTRACEUTICALS, LLC d/b/a Valensa International | Krill oil and reacted astaxanthin composition and associated method |
JP5735521B2 (ja) | 2009-10-30 | 2015-06-17 | タロス・リミテッドTharos Ltd. | リン脂質および中性脂質が強化されたオキアミ油を得る無溶媒の方法 |
KR101656121B1 (ko) | 2010-03-17 | 2016-09-08 | 노바리크 게엠베하 | 안압 증가를 치료하기 위한 약학 조성물 |
EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
EP2462921A1 (en) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
PL2714010T3 (pl) | 2011-05-25 | 2017-08-31 | Novaliq Gmbh | Kompozycja farmaceutyczna do miejscowego stosowania oparta na semifluorowanych alkanach |
EP2714008B1 (en) | 2011-05-25 | 2016-12-14 | Novaliq GmbH | Pharmaceutical composition for administration to nails |
US10383839B2 (en) * | 2011-06-30 | 2019-08-20 | Johnson & Johnson Vision Care, Inc. | Esters for treatment of ocular inflammatory conditions |
US9381183B2 (en) * | 2012-07-18 | 2016-07-05 | Physicians Recommended Nutriceuticals, Llc | Methods for improving the quality of the meibum composition of meibomian glands |
ES2565402T3 (es) * | 2011-09-12 | 2016-04-04 | Tassos GEORGIOU | Uso de los ácidos grasos omega para el tratamiento de enfermedades |
EP2794550B1 (en) | 2011-12-23 | 2019-02-20 | University of Western Sydney | Ophthalmic formulation |
WO2013110621A1 (en) | 2012-01-23 | 2013-08-01 | Novaliq Gmbh | Stabilised protein compositions based on semifluorinated alkanes |
JP2015526515A (ja) * | 2012-08-31 | 2015-09-10 | ボシュ・アンド・ロム・インコーポレイテッドBausch & Lomb Incorporated | オメガ3脂肪酸を有する眼用組成物 |
CN113679697A (zh) | 2012-09-12 | 2021-11-23 | 诺瓦利克有限责任公司 | 包含半氟化烷烃的混合物的组合物 |
JP6039152B2 (ja) | 2012-09-12 | 2016-12-07 | ノバリック ゲーエムベーハー | 半フッ素化アルカン組成物 |
KR102272568B1 (ko) | 2013-07-23 | 2021-07-05 | 노바리크 게엠베하 | 안정화 항체 조성물 |
CA2942050A1 (en) * | 2014-03-13 | 2015-09-17 | Barry D. Sears | Compositions and methods for reducing chronic low-level inflammation |
UA121399C2 (uk) * | 2014-11-25 | 2020-05-25 | Аллерган, Інк. | Стабілізовані композиції для офтальмологічного застосування, які містять омега-3-кислоти |
WO2016162894A1 (en) * | 2015-04-08 | 2016-10-13 | For Health Pharma S.R.L. | Ophthalmic compositions based on polyunsaturated fatty acids and triacylglycerols |
WO2016179137A1 (en) * | 2015-05-04 | 2016-11-10 | Cytometix, Inc. | Compositions and methods for delivery of polyunsaturated fatty acid derivatives and analogs |
DE202016008738U1 (de) | 2015-09-30 | 2019-04-09 | Novaliq Gmbh | Semifluorierte Verbindungen und ihre Zusammensetzungen |
CN108349855B (zh) | 2015-09-30 | 2021-07-20 | 诺瓦利克有限责任公司 | 用于眼部给药的半氟化化合物 |
CN109562124A (zh) | 2016-04-27 | 2019-04-02 | 安尼卡医疗有限公司 | 用于处理肌腱退化的方法和组合物 |
ES2763121T3 (es) | 2016-06-23 | 2020-05-27 | Novaliq Gmbh | Método de administración tópica |
ES2650981B2 (es) * | 2016-07-20 | 2018-05-04 | Ocupharm Diagnostics, Sl | Preparación y uso de un extracto de Artemia salina para tratar la superficie ocular |
EP3515422A1 (en) | 2016-09-21 | 2019-07-31 | Avexxin AS | Pharmaceutical composition |
CN116172987A (zh) | 2016-09-22 | 2023-05-30 | 诺瓦利克有限责任公司 | 用于治疗睑缘炎的药物组合物 |
US10813976B2 (en) | 2016-09-23 | 2020-10-27 | Novaliq Gmbh | Ophthalmic compositions comprising ciclosporin |
US10786441B2 (en) | 2016-11-21 | 2020-09-29 | Skinintegra, Inc. | Skin barrier repair and maintenance composition |
CN110678207A (zh) | 2017-04-21 | 2020-01-10 | 诺瓦利克有限责任公司 | 碘组合物 |
US11278503B2 (en) | 2017-05-12 | 2022-03-22 | Novaliq Gmbh | Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions |
CN111372566A (zh) | 2017-09-27 | 2020-07-03 | 诺瓦利克有限责任公司 | 用于治疗眼部疾病的包含拉坦前列素的眼科用组合物 |
CN111182893A (zh) | 2017-10-04 | 2020-05-19 | 诺瓦利克有限责任公司 | 包含f6h8的眼用组合物 |
SG11202007858VA (en) | 2018-03-02 | 2020-09-29 | Novaliq Gmbh | Pharmaceutical compositions comprising nebivolol |
BR112020022083A2 (pt) | 2018-05-01 | 2021-02-02 | Chibi, Inc. | depot líquido, estojo e método para tratar a retina. |
KR20210003877A (ko) | 2018-05-01 | 2021-01-12 | 치비 인코포레이티드 | 약제를 눈에 비침습적으로 지속 전달하기 위한 액체 데포 |
NO345574B1 (en) * | 2018-06-19 | 2021-04-26 | Epax Norway As | Composition for treatment of dry eye disease and meibomianitis |
SG11202102820VA (en) | 2018-10-12 | 2021-04-29 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
JP2022503799A (ja) * | 2018-10-22 | 2022-01-12 | ディーエスエム アイピー アセッツ ビー.ブイ. | 向上した酸化安定性を示す組成物 |
KR102275250B1 (ko) * | 2018-12-21 | 2021-07-08 | 윤영선 | 셀레늄과 프로폴리스를 유효성분으로 포함하는 안구 건조증 예방 및 치료용 조성물 |
WO2021194360A1 (en) * | 2020-03-27 | 2021-09-30 | Pharmazen Limited | Extraction method for bio-active fractions |
CN114073670B (zh) * | 2020-08-11 | 2023-02-24 | 武汉科福新药有限责任公司 | 马来酸噻吗洛尔凝胶滴眼液及其制备方法 |
MX2021003369A (es) * | 2021-03-22 | 2022-09-23 | Laboratorios Grin S A De C V | Lágrima ocular triple. |
US11951123B2 (en) | 2022-01-12 | 2024-04-09 | Platform Ophthalmic Innovations, LLC | Fortified nutritional lubricating drops for dry eye disease |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2013755C (en) | 1989-04-05 | 1993-11-30 | Simon Benita | Medicinal emulsions |
JP2873530B2 (ja) * | 1991-12-13 | 1999-03-24 | 参天製薬株式会社 | ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤 |
US6201022B1 (en) * | 1997-03-27 | 2001-03-13 | Myorx, Inc. | Methods for treating neurotransmitter-mediated pain syndromes by topically administering an omega fatty acid |
IT1304406B1 (it) * | 1998-10-21 | 2001-03-19 | Danital Italia S R L | Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3. |
PT102509A (pt) * | 2000-08-16 | 2002-02-28 | Fundacao Essprit Icarus | Composicoes farmaceuticas, cosmeticas e dermo-cosmeticas, de higiene, alimentares e para-alimentares a base de oleo de foca, e sua utilizacao |
US20040076695A1 (en) * | 2002-07-08 | 2004-04-22 | Advanced Vision Research | EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
US20040208939A1 (en) * | 2003-04-18 | 2004-10-21 | Barry Sears | Novel dietary compositions to reduce inflammation |
US7390507B2 (en) * | 2004-04-13 | 2008-06-24 | Ruwart Mary J | Compositions and methods for the treatment of radiation burns and other traumatic skin conditions |
NZ552481A (en) * | 2004-07-01 | 2008-12-24 | Schepens Eye Res | Compositions and methods for treating eye disorders and conditions |
AU2006322990A1 (en) * | 2005-10-07 | 2007-06-14 | Ocean Nutrition Canada Ltd. | Salts of fatty acids and methods of making and using thereof |
US20070207116A1 (en) * | 2006-03-01 | 2007-09-06 | Brown David C | Antioxidant compositions for the eye |
CA2646424C (en) * | 2006-03-17 | 2015-12-29 | Johnson & Johnson Vision Care, Inc. | Methods for stabilizing oxidatively unstable compositions |
-
2009
- 2009-03-19 IT ITRM2009A000119A patent/IT1393419B1/it active
-
2010
- 2010-03-18 CA CA2754568A patent/CA2754568C/en active Active
- 2010-03-18 WO PCT/IT2010/000119 patent/WO2010106571A2/en active Application Filing
- 2010-03-18 CN CN201080012341.0A patent/CN102355889B/zh active Active
- 2010-03-18 SI SI201031418A patent/SI2408426T1/sl unknown
- 2010-03-18 BR BRPI1009281A patent/BRPI1009281A2/pt not_active Application Discontinuation
- 2010-03-18 EP EP10717302.3A patent/EP2408426B1/en active Active
- 2010-03-18 PT PT107173023T patent/PT2408426T/pt unknown
- 2010-03-18 RU RU2011142146/15A patent/RU2545675C2/ru active
- 2010-03-18 US US13/256,994 patent/US8957110B2/en active Active
- 2010-03-18 HU HUE10717302A patent/HUE031869T2/en unknown
- 2010-03-18 RS RS20170253A patent/RS55859B1/sr unknown
- 2010-03-18 PL PL10717302T patent/PL2408426T3/pl unknown
- 2010-03-18 KR KR1020117021744A patent/KR101677308B1/ko active IP Right Grant
- 2010-03-18 MX MX2011009740A patent/MX2011009740A/es active IP Right Grant
- 2010-03-18 ES ES10717302.3T patent/ES2617683T3/es active Active
- 2010-03-18 DK DK10717302.3T patent/DK2408426T3/en active
-
2012
- 2012-08-01 HK HK12107538.0A patent/HK1166714A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
RU2011142146A (ru) | 2013-04-27 |
DK2408426T3 (en) | 2017-03-27 |
EP2408426A2 (en) | 2012-01-25 |
CN102355889B (zh) | 2015-01-28 |
BRPI1009281A2 (pt) | 2016-03-08 |
WO2010106571A3 (en) | 2010-11-18 |
WO2010106571A2 (en) | 2010-09-23 |
US8957110B2 (en) | 2015-02-17 |
CA2754568C (en) | 2017-07-18 |
ES2617683T3 (es) | 2017-06-19 |
ITRM20090119A1 (it) | 2010-09-19 |
KR20110130431A (ko) | 2011-12-05 |
PL2408426T3 (pl) | 2017-07-31 |
HK1166714A1 (en) | 2012-11-09 |
CN102355889A (zh) | 2012-02-15 |
RU2545675C2 (ru) | 2015-04-10 |
IT1393419B1 (it) | 2012-04-20 |
MX2011009740A (es) | 2011-09-29 |
RS55859B1 (sr) | 2017-08-31 |
US20120010280A1 (en) | 2012-01-12 |
HUE031869T2 (en) | 2017-08-28 |
PT2408426T (pt) | 2017-03-06 |
CA2754568A1 (en) | 2010-09-23 |
KR101677308B1 (ko) | 2016-11-17 |
EP2408426B1 (en) | 2016-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2408426T3 (pl) | Kompozycje dooczne na bazie wielonienasyconych kwasów tłuszczowych omega-3 i omega-6 | |
IL266231B (en) | Compounds of omega-3 polyunsaturated fatty acids are enriched in dpa in the form of fat in the free acid phase | |
HK1232207A1 (zh) | 多不飽和脂肪酸的衍生物作為藥物的用途 | |
HK1198544A1 (en) | Microbial oils enriched in polyunsaturated fatty acids | |
EP2197289A4 (en) | SOLID FAT COMPOSITIONS CONTAINING MULTIPLE UNSATURATED FATTY ACIDS AND THEIR USES AND MANUFACTURING | |
HK1205645A1 (en) | Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids rrr- | |
EP2358882A4 (en) | ENZYMES AND METHODS FOR PRODUCING OMEGA-3 FATTY ACIDS | |
IL228516A (en) | A compound for oral administration containing an omega-3 fatty acid ester and rosovastatin | |
EP2136844A4 (en) | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | |
GB2444896B (en) | Compositions comprising polyunsaturated fatty acids | |
EP2247201A4 (en) | FOOD PRODUCTS CONTAINING OMEGA-3 FATTY ACIDS | |
ZA201302760B (en) | Novel omega-3 and omega-6 fatty acid compositions and uses thereof | |
IL218460A0 (en) | Omega-3 fatty acid enriched shortenings and nut butters | |
GB201304550D0 (en) | Conjugates of polyunsaturated fatty acids and amine-containing compounds and uses thereof | |
EP2931065A4 (en) | PROCESS FOR PREPARING AND COMPOSITIONS WITH VEGETABLE OMEGA-3 FATTY ACIDS | |
EP2317873A4 (en) | FRUIT PRODUCTS CONTAINING OMEGA-3 FATTY ACIDS | |
EP2699108A4 (en) | FINISHED WITH HIGH EFFICIENCY BY OMEGA-6 / OMEGA-3-BALANCED MULTIPLE-UNSATURATED FATTY ACIDS | |
EP2928314A4 (en) | OXIDIZED STABILIZED FATS CONTAINING OMEGA 3 POLYUNSATURATED FATTY ACIDS AND THEIR USES | |
EP2713725A4 (en) | OXIDATIVELY STABILIZED FATS WITH VERY LONG-ROW AND MULTIPLE-UNSATURATED OMEGA-3-FATTY ACIDS | |
ZA201103915B (en) | Nutrition composition containing omega-3 fatty acids and mcts |